Cite
HARVARD Citation
Khanna, D. et al. (n.d.). AB0627 Rise-ssc: a double-blind, randomised study evaluating the efficacy and safety of riociguat for the treatment of patients with diffuse cutaneous systemic sclerosis. Annals of the rheumatic diseases. pp. 1271-1272. [Online].